Plasminogen activator inhibitor-1 and -3 increase cell adhesion and motility of MDA-MB-435 breast cancer cells.
about
Mouse DESC1 is located within a cluster of seven DESC1-like genes and encodes a type II transmembrane serine protease that forms serpin inhibitory complexesPlasminogen activator inhibitor-1 promotes inflammatory process induced by cigarette smoke extraction or lipopolysaccharides in alveolar epithelial cellsActivated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction.Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycleActivated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1.Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment.The basic helix-loop-helix/leucine zipper transcription factor USF2 integrates serum-induced PAI-1 expression and keratinocyte growthAntimetastatic potential of PAI-1-specific RNA aptamers.The ternary complex factor Net regulates cell migration through inhibition of PAI-1 expressionVariation in innate immunity genes and risk of multiple myelomaSERPINE1 (PAI-1) is a prominent member of the early G0 --> G1 transition "wound repair" transcriptome in p53 mutant human keratinocytes.SERPINE1 (PAI-1) is deposited into keratinocyte migration "trails" and required for optimal monolayer wound repairObesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1Old dogs and new tricks: proteases, inhibitors, and cell migration.Effects of plasminogen activator inhibitor-1-specific RNA aptamers on cell adhesion, motility, and tube formation.Intracellular Expression of PAI-1 Specific Aptamers Alters Breast Cancer Cell Migration, Invasion and Angiogenesis.Plasminogen activator inhibitor-1 inhibitors: a patent review (2006-present).Involvement of urokinase-type plasminogen activator system in cancer: an overview.From plasminogen to plasmin: role of plasminogen receptors in human cancer.Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism.Activity-based protein profiling implicates urokinase activation as a key step in human fibrosarcoma intravasation.The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1.Challenging delivery of VLHL NS plasminogen activator inhibitor-1 by osmotic pumps in diabetic mouse: A case report.Plasminogen activator inhibitor 1 protects fibrosarcoma cells from etoposide-induced apoptosis through activation of the PI3K/Akt cell survival pathway.Grassystatins D-F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast Cancer.Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.The contributions of integrin affinity and integrin-cytoskeletal engagement in endothelial and smooth muscle cell adhesion to vitronectin.
P2860
Q24301907-2DE1D47D-FE03-4A0E-8C14-ED6F084908FDQ24317592-C13CEE05-4CBB-4512-8CC8-9715C7E53C67Q33615455-FBA55C18-3A3A-4809-A1F1-33D54741D422Q33715393-69D4E9DC-4BAA-4E5B-A6E9-E71ECA932B1BQ33749766-3F47BD77-2A74-4645-98AD-25075A0E1214Q33812093-87BDFD4C-C582-4D4C-A720-EB001AF51479Q34052832-0B66BE80-C96C-4430-ACFF-9C76DA1A49E6Q34167905-A3DE9B61-7019-462D-992E-9467CAA0D297Q34230893-BA301EF8-6FFD-418F-8A95-87FF27F4FB3DQ34306330-2AAA142A-02BB-4132-B87F-B84A380FD005Q34691253-63144356-2DD3-4E05-9014-B2777E39EE52Q34767246-FE327856-7FC3-4E13-A3AF-D294B27BBCB0Q34996841-941C45EA-9915-43EC-A7F9-CFEE9EC7E7CCQ35167706-1EFDAD1E-F644-4861-AEC3-F090748862A6Q35757741-23D8F64B-DDF2-4615-93E8-6E535CB55309Q36166157-2A58925A-4EDF-4459-A9B1-FE9FA0875F63Q38092174-A5BB30EB-4AAE-4102-A337-78A6D939F6E2Q38189275-1D1B6DF2-3A12-4E44-8285-5623622A6485Q38269342-4087B1A1-B8BA-4C79-8F9D-0A5FC6C64C10Q39846676-9F8F6B96-28A7-4506-AF11-123A49EA5008Q40293146-CF673FC5-E238-4689-97BC-A5F3F3A6C7CDQ40582221-82B78BCE-260F-4320-B082-8D830049483FQ41493665-F5C14FA2-C842-421F-8D80-90165A5AC9D9Q42136467-30B2BB03-AD09-48D7-9B2B-9EC23BB5F29AQ47583201-8F5475CA-043B-46EF-B95D-D97D2CD82BCDQ51491433-9643820B-C1D4-4D66-8861-0444CDEC6357Q52578122-52C0FA61-EEB7-43B1-B9D2-6886F144D5FC
P2860
Plasminogen activator inhibitor-1 and -3 increase cell adhesion and motility of MDA-MB-435 breast cancer cells.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Plasminogen activator inhibito ...... DA-MB-435 breast cancer cells.
@en
Plasminogen activator inhibito ...... DA-MB-435 breast cancer cells.
@nl
type
label
Plasminogen activator inhibito ...... DA-MB-435 breast cancer cells.
@en
Plasminogen activator inhibito ...... DA-MB-435 breast cancer cells.
@nl
prefLabel
Plasminogen activator inhibito ...... DA-MB-435 breast cancer cells.
@en
Plasminogen activator inhibito ...... DA-MB-435 breast cancer cells.
@nl
P2093
P2860
P356
P1476
Plasminogen activator inhibito ...... MDA-MB-435 breast cancer cells
@en
P2093
Diane Palmieri
Frank C Church
Rudy L Juliano
P2860
P304
40950-40957
P356
10.1074/JBC.M202333200
P407
P577
2002-08-09T00:00:00Z